{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:57:06Z","timestamp":1784649426980,"version":"3.55.0"},"reference-count":27,"publisher":"Oncology Nursing Society (ONS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1188\/18.cjon.438-443","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T08:33:12Z","timestamp":1532334792000},"page":"438-443","source":"Crossref","is-referenced-by-count":5,"title":["Cannabis Use and Bleomycin: An Overview and Case Study of Pulmonary Toxicity"],"prefix":"10.1188","volume":"22","author":[{"given":"Sarah","family":"Merkle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abrams, D.I. (2016). Integrating cannabis into clinical cancer care. Current Oncology, 23, S8\u2013S14.","DOI":"10.3747\/co.23.3099"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Abrams, D.I., & Guzman, M. (2015). Cannabis in cancer care. Clinical Pharmacology and Therapeutics, 97, 575\u2013586. https:\/\/doi.org\/10.1002\/cpt.108","DOI":"10.1002\/cpt.108"},{"key":"3","unstructured":"Bedford Laboratories. (2009). Bleomycin [Package insert]. Bedford, OH: Author."},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bowles, D.W., O\u2019Bryant, C.L., Camidge, D.R., & Jimeno, A. (2012). The intersection between cannabis and cancer in the United States. Critical Reviews in Oncology\/Hematology, 83, 1\u201310. https:\/\/doi.org\/10.1016\/j.critrevonc.2011.09.008","DOI":"10.1016\/j.critrevonc.2011.09.008"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Budney, A.J., Sargent, J.D., & Lee, D.C. (2015). Vaping cannabis (marijuana): Parallel concerns to e-cigs? Addiction, 110, 1699\u20131704. https:\/\/doi.org\/10.1111\/add.13036","DOI":"10.1111\/add.13036"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Clark, C.S. (2018). Medical cannabis: The oncology nurse\u2019s role in patient education about the effects of marijuana on cancer palliation [Online exclusive]. Clinical Journal of Oncology Nursing, 22, E1\u2013E6. https:\/\/doi.org\/10.1188\/18.CJON.E1-E6","DOI":"10.1188\/18.CJON.E1-E6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cridge, B.J., & Rosengren, R.J. (2013). Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Management and Research, 5, 301\u2013313. https:\/\/doi.org\/10.2147\/CMAR.S36105","DOI":"10.2147\/CMAR.S36105"},{"key":"8","unstructured":"Feldman, D., & Vander Els, N. (2017). Bleomycin-induced lung injury. In H. Hollingsworth & D.M.F. Savarese (Eds.), UpToDate\u00ae. Retrieved from https:\/\/www.uptodate.com\/contents\/bleomycin-induced-lung-injury"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Gordon, A.J., Conley, J.W., & Gordon, J.M. (2013). Medical consequences of marijuana use: A review of current literature. Current Psychiatry Reports, 15, 419. https:\/\/doi.org\/10.1007\/s11920-013-0419-7","DOI":"10.1007\/s11920-013-0419-7"},{"key":"10","unstructured":"Governing. (2018, March 30). State marijuana laws in 2018 map. Retrieved from http:\/\/www.governing.com\/gov-data\/state-marijuana-laws-map-medical-recre..."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Guindon, J., & Hohmann, A.G. (2011). The endocannabinoid system and cancer: Therapeutic implication. British Journal of Pharmacology, 163, 1447\u20131463. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01327.x","DOI":"10.1111\/j.1476-5381.2011.01327.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"He, T., Oks, M., Esposito, M., Steinberg, H., & Makaryus, M. (2017). \u201cTree-in-bloom\u201d: Severe acute lung injury induced by vaping cannabis oil. Annals of the American Thoracic Society, 14, 468\u2013470. https:\/\/doi.org\/10.1513\/AnnalsATS.201612-974LE","DOI":"10.1513\/AnnalsATS.201612-974LE"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hill, K.P. (2015). Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA, 313, 2474\u20132483. https:\/\/doi.org\/10.1001\/jama.2015.6199","DOI":"10.1001\/jama.2015.6199"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hoskin, P.J., Lowry, L., Horwich, A., Jack, A., Mead, B., Hancock, B.W., . . . Johnson, P.W. (2009). Randomized comparison of the Stanford V regimen and ABVD in the treatment of advanced Hodgkin\u2019s lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. Journal of Clinical Oncology, 27, 5390\u20135396. https:\/\/doi.org\/10.1200\/JCO.2009.23.3239","DOI":"10.1200\/JCO.2009.23.3239"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Lee, M.H., & Hancox, R.J. (2011). Effects of smoking cannabis on lung function. Expert Review of Respiratory Medicine, 5, 537\u2013546. https:\/\/doi.org\/10.1586\/ers.11.40","DOI":"10.1586\/ers.11.40"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Martin, W.G., Ristow, K.M., Habermann, T.M., Colgan, J.P., Witzig, T.E., & Ansell, S.M. (2005). Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin\u2019s lymphoma. Journal of Clinical Oncology, 23, 7614\u20137620. https:\/\/doi.org\/10.1200\/JCO.2005.02.7243","DOI":"10.1200\/JCO.2005.02.7243"},{"key":"17","unstructured":"Meuche, G. (2017, March 29). The integration of cannabis in oncologic care. Oncology Nurse Advisor. Retrieved from http:\/\/www.oncologynurseadvisor.com\/side-effect-management\/use- of-cannabis-in-cancer-care\/article\/647302\/2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Owen, K.P., Sutter, M.E., & Albertson, T.E. (2013). Marijuana: Respiratory tract effects. Clinical Reviews in Allergy and Immunology, 46, 65\u201381. https:\/\/doi.org\/10.1007\/s12016-013-8374-y","DOI":"10.1007\/s12016-013-8374-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Palumbo-Zerr, K., Horn, A., Distler, A., Zerr, P., Dees, C., Beyer, C., . . . Distler, J.H. (2012). Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1. Annals of the Rheumatic Diseases, 71, 2051\u20132054. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201823","DOI":"10.1136\/annrheumdis-2012-201823"},{"key":"20","unstructured":"Pizzorno, J. (2016). What should we tell our patients about marijuana (Cannabis indica and Cannabis sativa)? Integrative Medicine, 15(6), 8\u201312."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Pomahacova, B., Van der Kooy, F., and Verpoorte, R. (2009). Cannabis smoke condensate III: The cannabinoid content of vaporised cannabis sativa. Inhalation Toxicology, 21, 1108\u20131112. https:\/\/doi.org\/10.3109\/08958370902748559","DOI":"10.3109\/08958370902748559"},{"key":"22","unstructured":"Rahn, B. (2015, October 20). What are the best cannabis strains for cancer-related symptoms? Leafly. Retrieved from https:\/\/www.leafly.com\/news\/strains-products\/what-are-the-best-strains-f..."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Ribeiro, L.I., & Ind, P.W. (2016). Effect of cannabis smoking on lung function and respiratory symptoms: A structured literature review. npj Primary Care Respiratory Medicine, 26, 16071.","DOI":"10.1038\/npjpcrm.2016.71"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Russo, E.B. (2016). Current therapeutic cannabis controversies and clinical trial design issues. Frontiers in Pharmacology, 7, 309. https:\/\/doi.org\/10.3389\/fphar.2016.00309","DOI":"10.3389\/fphar.2016.00309"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Schrot, R.J., & Hubbard, J.R. (2016). Cannabinoids: Medical implications. Annals of Medicine, 48, 128\u2013141. https:\/\/doi.org\/10.3109\/07853890.2016.1145794","DOI":"10.3109\/07853890.2016.1145794"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Sun, H., Atenafu, E.G., Tsang, R., Kukreti, V., Marras, T.K., Crump, M., & Kuruvilla, J. (2017). Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma. Leukemia and Lymphoma, 58, 2607\u20132614. https:\/\/doi.org\/10.1080\/10428194.2017.1307980","DOI":"10.1080\/10428194.2017.1307980"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Tashkin, D.P. (2015). How beneficial is vaping cannabis to respiratory health compared to smoking? Addiction, 110, 1706\u20131707. https:\/\/doi.org\/10.1111\/add.13075","DOI":"10.1111\/add.13075"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/22\/4\/cannabis-use-and-bleomycin-overview-and-case-study-pulmonary-toxicity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:24Z","timestamp":1763754684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/22\/4\/cannabis-use-and-bleomycin-overview-and-case-study-pulmonary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1188\/18.cjon.438-443","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}